Commitments and Contingencies (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
|---|
| Commitments And Contingencies Disclosure [Abstract] |
|
| Schedule of Lease Term and Discount Rate |
Financing liability information is as follows (in thousands):
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
|
Weighted average remaining lease term (in years) |
|
|
18.8 |
|
|
|
19.8 |
|
|
Weighted average discount rate |
|
|
9.0 |
% |
|
|
9.0 |
% |
Lease information is as follows (in thousands):
|
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
|
Operating lease right-of-use assets(1) |
|
$ |
6,714 |
|
|
$ |
2,284 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating lease liability-current (2) |
|
$ |
1,304 |
|
|
$ |
1,380 |
|
|
Operating lease liability-long-term |
|
|
5,343 |
|
|
|
1,040 |
|
|
Total |
|
$ |
6,647 |
|
|
$ |
2,420 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average remaining lease term (in years) |
|
|
4.6 |
|
|
|
2.6 |
|
|
Weighted average discount rate |
|
|
7.3 |
% |
|
|
7.3 |
% |
|
| Summary of Lease Information |
|
|
|
December 31, |
|
|
|
|
2022 |
|
|
2021 |
|
|
Interest expense on financing liability |
|
$ |
9,758 |
|
|
$ |
1,373 |
|
|
|
|
December 31, |
|
|
|
|
2022 |
|
|
2021 |
|
|
2020 |
|
|
Operating lease costs |
|
$ |
1,525 |
|
|
$ |
863 |
|
|
$ |
1,403 |
|
|
Variable lease costs |
|
|
274 |
|
|
|
515 |
|
|
|
394 |
|
|
Cash paid |
|
|
1,823 |
|
|
|
1,867 |
|
|
|
1,797 |
|
|
| Summary of Financing Liability Payments |
Financing liability payments as of December 31, 2022 was as follows (in thousands):
|
|
|
December 31, 2022 |
|
|
2023 |
|
$ |
9,774 |
|
|
2024 |
|
|
10,018 |
|
|
2025 |
|
|
10,269 |
|
|
2026 |
|
|
10,533 |
|
|
2027 |
|
|
10,849 |
|
|
Thereafter |
|
|
188,453 |
|
|
Total |
|
|
239,896 |
|
|
Interest payments |
|
|
(132,936 |
) |
|
Debt issuance costs |
|
|
(2,883 |
) |
|
Total financing liability |
|
$ |
104,077 |
|
|
| Remaining Purchase Requirements |
In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $2.0 million of amendment fees, which were recognized in cost of goods sold for the year ended December 31, 2021. The remaining purchase commitments as of December 31, 2022 were as follows ( € in millions):
|
|
December 31, 2022 |
|
|
2023 |
|
|
8.8 |
|
|
2024 |
|
|
14.6 |
|
|
2025 |
|
|
15.5 |
|
|
2026 |
|
|
19.4 |
|
|
2027 |
|
|
9.2 |
|
|
| Schedule of Future Minimum Office And Vehicle Lease Payments |
Future minimum office and vehicle lease payments as of December 31, 2022 are as follows (in thousands):
|
|
|
December 31, 2022 |
|
|
2023 |
|
$ |
1,368 |
|
|
2024 |
|
|
1,892 |
|
|
2025 |
|
|
1,861 |
|
|
2026 |
|
|
1,140 |
|
|
2027 |
|
|
1,072 |
|
|
Thereafter |
|
|
643 |
|
|
Total |
|
|
7,976 |
|
|
Interest expense |
|
|
(1,329 |
) |
|
Total operating lease liability |
|
$ |
6,647 |
|
|